Showing results (541-550 of 601) with videos related to

Sort By:
Pageof 61
Neuro-Oncology|December 10, 2023
Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effortJoshua A Budhu, Ugonma N Chukwueke, Sadhana Jackson, et al.
Nanomaterials (Basel, Switzerland)|May 14, 2022
The Effect of Agglomeration on Arsenic Adsorption Using Iron Oxide NanoparticlesWilliam R Diephuis, Anna L Molloy, Lindsey L Boltz, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 12, 2026
Implementing an Evidence-Based Guideline to Improve Perioperative Antimicrobial Prophylaxis Quality Among Patients With Penicillin Allergy LabelsSarah Lessard, Alexei Gonzalez-Estrada, Steven B Porter, et al.
Haematologica|January 25, 2012
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Haematologica|November 13, 2010
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Clinical Medicine Insights. Oncology|March 27, 2023
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from MelanomaHolly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, et al.
Blood Cells, Molecules & Diseases|August 17, 2011
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trialsAurelio Maggio, Aldo Filosa, Angela Vitrano, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 17, 2025
Tumor treating fields utilization and efficacy for glioblastoma at a large multicenter academic practiceDavid J Crompton, Shelby Kern, Aaron Bogan, et al.
Blood|December 10, 2009
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemiaDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Pageof 61